Marcia Frellick

Marcia Frellick is a freelance journalist who has been contributing to Medscape since 2016. She has covered a wide range of topics, including medical news, health, and science. Her work is characterized by a clear and concise writing style, and she is known for her ability to explain complex medical topics in a way that is accessible to the general public.

97%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

95%

Examples:

  • In the article 'Pfizer, BioNTech Start Phase 3 Trial of COVID-19/Flu Vaccine', there seems to be a bias towards Pfizer and BioNTech, as it does not mention any potential competitors or alternative treatments.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

100%

Examples:

No current examples available.

Recent Articles

Half of Long COVID Patients Show No Improvement After 18 Months; Older Adults Remain Most Vulnerable Despite High Vaccination Rates

Broke On: Monday, 30 October 2023 Approximately half of long COVID patients see no improvement even after 18 months, regardless of the variant they were infected with. The most common symptoms of long COVID are fatigue, difficulty concentrating, and memory problems. Despite high vaccination rates, older adults remain the most vulnerable to COVID-19 due to factors such as weakened immune systems and underlying health conditions.

Pfizer and BioNTech Initiate Phase 3 Trial for Combination COVID-19 and Flu Vaccine

Broke On: Thursday, 26 October 2023 Pfizer and BioNTech have started a Phase 3 trial for a combination COVID-19 and flu vaccine. The vaccine uses mRNA technology and aims to simplify the vaccination process. The trial's announcement has led to mixed reactions in the stock market.

Study Suggests Potential Link Between Adult ADHD and Increased Dementia Risk

Broke On: Thursday, 26 October 2023 A recent study by Rutgers University suggests that adults with ADHD may be three times more likely to develop dementia. The study involved a comprehensive analysis of health records of over 1.9 million adults. The study does not establish a direct cause-and-effect relationship between ADHD and dementia, but rather an association. Shared risk factors between ADHD and dementia, such as genetics, brain injuries, or other mental health disorders, could be the reason for the increased risk. Having ADHD does not guarantee an individual will develop dementia.